Top > Search of International Patents > DYSPHAGIA THERAPEUTIC AGENT

DYSPHAGIA THERAPEUTIC AGENT

Foreign code F150008273
Posted date Apr 3, 2015
Country WIPO
International application number 2014JP061821
International publication number WO 2014181724
Date of international filing Apr 28, 2014
Date of international publication Nov 13, 2014
Priority data
  • P2013-100119 (May 10, 2013) JP
  • P2014-016749 (Jan 31, 2014) JP
Title DYSPHAGIA THERAPEUTIC AGENT
Abstract The purpose of the present invention is to provide a means for alleviating dysphagia, without changing the inherent physical properties of a food or beverage or taking a stimulating substance with food or before or after eating. Provided is a therapeutic agent for treating dysphagia that contains a TRPV1 agonist, and that is used so as to be applied to the external auditory canal.
Scope of claims (In Japanese)[請求項1]
TRPV1作動剤を含み、外耳道に適用するように用いられる、嚥下障害の治療薬。
[請求項2]
カプサイシン化合物又はメントールを含み、外耳道に適用するように用いられる、嚥下障害の治療薬。
[請求項3]
更に、薬学的に許容可能な賦形剤を含む、項1又は2に記載の治療薬。
[請求項4]
外耳道に1日1回~1週間に1回の頻度で反復適用される、請求項1~3に記載の治療薬。
[請求項5]
TRPV1作動剤を含み、外耳道に適用するように用いられる、嚥下性肺炎の予防薬。
[請求項6]
カプサイシン化合物又はメントールを含み、外耳道に適用するように用いられる、嚥下性肺炎の予防薬。
  • Applicant
  • ※All designated countries except for US in the data before July 2012
  • UNIVERSITY OF TOKUSHIMA
  • Inventor
  • TAKEDA NORIAKI
  • JINNOUCHI OSAMU
IPC(International Patent Classification)
Specified countries National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LT LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN TD TG
Please contact us by E-mail or facsimile if you have any interests on this patent.

PAGE TOP

close
close
close
close
close
close